Erratum: Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci. 28 (2007) 75-82 (DOI:10.1016/j.tips.2006.12.006);Ca2+ channel α2δ ligands: novel modulators of neurotransmission

Trends in Pharmacological Sciences

Volumn 28, Issue 2, 2007, Pages 75-82

  Dooley, David J ^a   Taylor, Charles P ^a   Donevan, Sean ^a   Feltner, Douglas ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL ALPHA 2 DELTA LIGAND; GABAPENTIN; NEUROTRANSMITTER; PREGABALIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; LIGAND; VOLTAGE GATED CALCIUM CHANNEL SUBUNIT CA ALPHA2DELTA 1, HUMAN; VOLTAGE GATED CALCIUM CHANNEL SUBUNIT CA ALPHA2DELTA-1, HUMAN;

ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFECT; FIBROMYALGIA; FOCAL EPILEPSY; GENERALIZED ANXIETY DISORDER; HUMAN; LIGAND BINDING; MENTAL DISEASE; MODULATION; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SOMNOLENCE; ANIMAL; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; BINDING SITES; CALCIUM CHANNELS; HUMANS; LIGANDS; SYNAPTIC TRANSMISSION;

EID: 33846520548     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.02.001     Document Type: Erratum

References (58)

1. Satzinger G. Antiepileptics from γ-aminobutyric acid. Arzneimittelforschung 44 (1994) 261-266
2. Silverman R.B., et al. 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase. J. Med. Chem. 34 (1991) 2295-2298
3. Taylor C.P., et al. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 14 (1993) 11-15
4. Yuen P.W., et al. Enantioselective synthesis of PD 144723: a potent stereospecific anticonvulsant. Bioorg. Med. Chem. Lett. 4 (1994) 823-826
5. 2δ subunit of a calcium channel and their evaluation as anticonvulsant agents. J. Med. Chem. 41 (1998) 1838-1845
6. 2δ protein. J. Med. Chem. 48 (2005) 3026-3035
7. Burgos-Lepley C.E., et al. Carboxylate bioisosteres of gabapentin. Bioorg. Med. Chem. Lett. 16 (2006) 2333-2336
8. 2δ protein. J. Med. Chem. 48 (2005) 2294-2307
9. 2δ subunit of voltage-gated calcium channels. Bioorg. Med. Chem. Lett. 14 (2004) 2463-2467
10. 2δ subunit of voltage-gated calcium channels. Bioorg. Med. Chem. Lett. 16 (2006) 1138-1141
11. Taylor C.P., et al. A summary of the mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29 (1998) 233-249
12. Bryans J.S., and Wustrow D.J. 3-Substituted GABA analogs with central nervous system activity: a review. Med. Res. Rev. 19 (1999) 149-177
13. 2δ subunit of a calcium channel. J. Biol. Chem. 271 (1996) 5768-5776
14. 2δ subunits - structure and gabapentin binding. Mol. Pharmacol. 59 (2001) 1243-1248
15. 2δ-4 subunit. Mol. Pharmacol. 62 (2002) 485-496
16. Maneuf Y.P., et al. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell. Mol. Life Sci. 60 (2003) 742-750
17. 3H]-gabapentin binding activity. J. Biol. Chem. 273 (1998) 25458-25465
18. 2δ for gabapentin binding. Biochem. J. 342 (1999) 313-320
19. 2δ type-1 genetically modified mice. Brain Res. 1075 (2006) 68-80
20. 1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17537-17542
21. Stefani A., et al. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 37 (1998) 83-91
22. 2+ channel currents in cultured sensory neurons is dependent on culture conditions and channel subunit expression. Neuropharmacology 42 (2002) 353-366
23. 2+ influx and synaptic transmission in rat hippocampus and neocortex. Eur. J. Pharmacol. 449 (2002) 221-228
24. 2δ subunits: structure, functions, and target site for drugs. Curr. Neuropharmacol. 1 (2003) 209-217
25. 2δ-1 subunit mediates spinal hyperexcitability in pain modulation. Pain 125 (2006) 20-34
26. Reimann W. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?. Eur. J. Pharmacol. 94 (1983) 341-344
27. Schlicker E., et al. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelforschung 35 (1985) 1347-1349
28. 3H]-norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J. Pharmacol. Exp. Ther. 295 (2000) 1086-1093
29. +-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci. Lett. 280 (2000) 107-110
30. Fehrenbacher J.C., et al. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105 (2003) 133-144
31. Cunningham M.O., et al. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur. J. Neurosci. 20 (2004) 1566-1576
32. 2+ channels. Neuropharmacology 46 (2004) 743-749
33. 2+ channel-mediated synaptic transmission in the hippocampus in vitro. Synapse 55 (2005) 262-269
34. 3H]-norepinephrine release from rat neocortical slices. Synapse 45 (2002) 171-190
35. Patel M.K., et al. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br. J. Pharmacol. 130 (2000) 1731-1734
36. 3H]-glutamate from rat caudal trigeminal nucleus slices. Pain 93 (2001) 191-196
37. Maneuf Y.P., and McKnight A.T. Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase. Br. J. Pharmacol. 134 (2001) 237-240
38. +-induced synaptosomal calcium influx by gabapentin. Brain Res. 875 (2000) 157-159
39. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42 (2002) 229-236
40. Micheva K.D., et al. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol. Pharmacol. 70 (2006) 467-476
41. Spafford J.D., and Zamponi G.W. Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery. Curr. Opin. Neurobiol. 13 (2003) 308-314
42. 3H]-Gabapentin may label a system-L-like neutral amino acid carrier in brain. Eur. J. Pharmacol. 247 (1993) 341-345
43. 3H]-leucine. Anal. Biochem. 255 (1998) 236-243
44. Perry T.L., et al. CSF amino acids and plasma-CSF amino acid ratios in adults. J. Neurochem. 24 (1975) 587-589
45. Freynhagen R., et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263
46. Rickels K., et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch. Gen. Psychiatry 62 (2005) 1022-1030
47. Crofford L.J., et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52 (2005) 1264-1273
48. Hindmarch I., et al. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology (Berl.) 183 (2005) 133-143
49. Triggle D.J. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance. Cleve. Clin. J. Med. 59 (1992) 617-627
50. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5 (2004) 553-564
51. Catterall W.A., et al. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57 (2005) 411-425
52. 2+ channel using electron cryo-microscopy. J. Mol. Biol. 332 (2003) 171-182
53. V2.1 into lipid rafts in cerebellum: implications for localization and function. J. Neurosci. 26 (2006) 8748-8757
54. 2δ) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J. Comp. Neurol. 491 (2005) 246-269
55. Curtis B.M., and Catterall W.A. Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules. Biochemistry 25 (1986) 3077-3083
56. Arikkath J., and Campbell K.P. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr. Opin. Neurobiol. 13 (2003) 298-307
57. 2+ channels. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11230-11235
58. 1 interaction domain. Neuron 42 (2004) 387-399